Bioretec Ltd Company announcement
An aggregate number of 125,487 new shares of
Following the registration of the new shares, the total number of registered shares in Bioretec is 14,111,858.
The new shares will be issued in the book-entry system on or about
No new shares may be subscribed for under the option program 2021-1.
Information about Bioretec
Bioretec's mission is to promote healing after trauma or orthopedic surgery, building on a unique understanding of bioresorbable medical implants that act as scaffolds for tissue growth and eliminate the need for removal surgery of the implants. Bioretec's bioresorbable polymer implants are used worldwide and the company intends to launch a new series of innovative implants based on a unique bioresorbable metallic alloy, RemeOsTM. The RemeOsTM product line is designed to meet the unmet medical need of demanding load-bearing fixations, and to facilitate a seamless transition for surgeons from conventional titanium implants. Better healing - Better life.
(c) 2021 Cision. All rights reserved., source